p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease

被引:23
作者
Cancino, Gonzalo I. [1 ,2 ]
Miller, Freda D. [2 ,3 ,4 ]
Kaplan, David R. [1 ,3 ]
机构
[1] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1L7, Canada
[2] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada
[3] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[4] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
p73; p53; family; Tau phosphorylation; Pin1; Alzheimer's disease; Aging; Neurodegeneration; GSK-3; beta; c-Abl; Cdk5; Tauopathy; Paired helical filaments; TgCRND8; PROLYL ISOMERASE PIN1; C-ABL; NEURONAL SURVIVAL; P53; FAMILY; PHOSPHORYLATION; CDK5; MAINTENANCE; PATHOLOGY; BRAIN; MICE;
D O I
10.1016/j.neurobiolaging.2012.04.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Haploinsufficiency for the p53 family member p73 causes behavioral and neuroanatomical correlates of neurodegeneration in aging mice, including the appearance of aberrant phospho-tau-positive aggregates. Here, we show that these aggregates and tau hyperphosphorylation, as well as a generalized dysregulation of the tau kinases GSK3 beta, c-Abl, and Cdk5, occur in the brains of aged p73+/- mice. To investigate whether p73 haploinsufficiency therefore represents a general risk factor for tau hyperphosphorylation during neurodegeneration, we crossed the p73+/- mice with 2 mouse models of neurodegeneration, TgCRND8+/empty set mice that express human mutant amyloid precursor protein, and Pin1-/- mice. We show that haploinsufficiency for p73 leads to the early appearance of phospho-tau-positive aggregates, tau hyperphosphorylation, and activation of GSK3 beta, c-Abl, and Cdk5 in the brains of both of these mouse models. Moreover, p73+/-; TgCRND8+/empty set mice display a shortened lifespan relative to TgCRND8+/empty set mice that are wild type for p73. Thus, p73 is required to protect the murine brain from tau hyperphosphorylation during aging and degeneration. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 399
页数:13
相关论文
共 50 条
[41]   Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction [J].
Lin, Zhi-Xiu ;
Yang, Wen ;
Xu, Qing-Qing ;
Yuan, Qiuju ;
Xian, Yan-Fang .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
[42]   Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease [J].
Zhang, Haibo ;
Wang, Ding ;
Gong, Ping ;
Lin, Aihua ;
Zhang, Yan ;
Ye, Richard D. ;
Yu, Yang .
JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (01) :169-179
[43]   Phosphorylated Tau in the Taste Buds of Alzheimer's Disease Mouse Models [J].
Kim, Hyun Ji ;
Kim, Bo Hye ;
Kim, Dong Kyu ;
Kim, Hanbin ;
Choi, Sang-Hyun ;
Kim, Dong-Hoon ;
Choi, Myunghwan ;
Mook-Jung, Inhee ;
Jeong, Yong Taek ;
Kwon, Obin .
EXPERIMENTAL NEUROBIOLOGY, 2024, 33 (04) :202-214
[44]   Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer's disease and tauopathy models [J].
Selvarasu, Karthikeyan ;
Singh, Abhay Kumar ;
Iyaswamy, Ashok ;
Gopalkrishnashetty Sreenivasmurthy, Sravan ;
Krishnamoorthi, Senthilkumar ;
Bera, Amal Kanti ;
Huang, Jian-Dong ;
Durairajan, Siva Sundara Kumar .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
[45]   Estradiol prevents neural Tau hyperphosphorylation characteristic of Alzheimer's disease [J].
Alvarez-De-La-Rosa, M ;
Silva, I ;
Nilsen, J ;
Pérez, MM ;
García-Segura, LM ;
Avila, J ;
Naftolin, F .
FUTURE OF HORMONE THERAPY: WHAT BASIC SCIENCE AND CLINICAL STUDIES TEACH US, 2005, 1052 :210-224
[46]   A direct interaction between RhoGDIα/Tau alleviates hyperphosphorylation of Tau in Alzheimer's disease and vascular dementia [J].
Heping Zhang ;
Fan Lu ;
Panhong Liu ;
Zhaohui Qiu ;
Jianling Li ;
Xiaotong Wang ;
Hui Xu ;
Yandong Zhao ;
Xuemin Li ;
Huadong Wang ;
Daxiang Lu ;
Renbin Qi .
Journal of Neuroimmune Pharmacology, 2023, 18 :58-71
[47]   A direct interaction between RhoGDIα/Tau alleviates hyperphosphorylation of Tau in Alzheimer's disease and vascular dementia [J].
Zhang, Heping ;
Lu, Fan ;
Liu, Panhong ;
Qiu, Zhaohui ;
Li, Jianling ;
Wang, Xiaotong ;
Xu, Hui ;
Zhao, Yandong ;
Li, Xuemin ;
Wang, Huadong ;
Lu, Daxiang ;
Qi, Renbin .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2023, 18 (1-2) :58-71
[48]   Aging and Alzheimer's disease connection: Nuclear Tau and lamin A [J].
Gil, Laura ;
Nino, Sandra A. ;
Capdeville, Gabriela ;
Jimenez-Capdeville, Maria E. .
NEUROSCIENCE LETTERS, 2021, 749
[49]   Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer's Disease [J].
Khadgawat, Priya ;
Siddesha, J. M. ;
Shashank, Dharini ;
Prasad, Shashanka K. .
JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) :405-411
[50]   S100β interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease [J].
Yu, WH ;
Fraser, PE .
JOURNAL OF NEUROSCIENCE, 2001, 21 (07) :2240-2246